Entourage Health Corp. (formerly WeedMD Inc.)
(
TSX-V:ENTG)
(OTCQX:ETRGF)
(FSE:4WE) (“
Entourage” or the
“
Company”), a Canadian producer and distributor of
award-winning cannabis products and brands, in collaboration with
leading Canadian retailer
Fire & Flower Inc.
(“
Fire & Flower”) (
TSX:FAF;
OTCQX:FFLWF), is pleased to announce the release of Fire
& Flower’s “Revity CBD™ Softgel” line. In addition to the CBD
softgels, the private-label Revity product line currently includes
CBD oils launched last year. Revity CBD products are available in
Saskatchewan retail locations and will expand into Ontario in
mid-September 2021, with Manitoba locations expected in the near
future.
Products manufactured through this partnership
are formulated, processed, packaged and distributed by Entourage at
its extraction and processing hub in Aylmer, Ontario using the
Company’s CBD-rich biomass.
“We congratulate Fire & Flower on the launch
of its Revity CBD Softgel line and we’re proud to be part of its
innovation and growth strategy in North America as this pioneering
team gauges local insights and commences its expansion into the US
market,” said George Scorsis, Interim CEO and Executive Chair,
Entourage. “Our industry is poised for collaboration and we’re
thrilled to align with retailers that heed consumer feedback and
focus on providing services and products to underserved
markets.”
“Ensuring that cannabis consumers have access to
quality-produced, regulated CBD products for their self-care needs
was the main reason for launching the Revity CBD product line and
we’re excited about this continued product expansion in
collaboration with the Entourage team,” said Trevor Fencott, CEO of
Fire & Flower. “We’ve garnered significant market insights with
our Hifyre cannabis digital platform – allowing us to better
understand consumer preferences nationwide and respond with the
right market offerings. This convenience-orientated cannabis retail
experience will serve us well as we now start expanding our
services and offerings in the US market.”
Entourage specializes in cultivation,
extraction, tolling, licensing and innovative third-party product
formulations from the Company’s fully-licensed facilities in
Strathroy and Aylmer, Ontario using its own cannabinoid-rich input
biomass. In addition to Fire & Flower, Entourage exclusively
produces and distributes U.S.-brand Mary’s Medicinals’ topical
balms in Canada with additional Mary’s products expected for
release in Q3 2021.
Visit Entourage Health’s newly launched website
here. To access our corporate video, visit us here and to access
our latest investor presentation and corporate deck here.
About Entourage Health
Corp.
Entourage Health Corp. (formerly WeedMD Inc.) is
the publicly traded parent company of WeedMD RX Inc. a licence
holder producing and distributing cannabis products for both the
medical and adult-use markets. The Company owns and operates a
158-acre state-of-the-art greenhouse, outdoor and processing
facility located in Strathroy, ON as well as a fully licensed
26,000 sq. ft. Aylmer, ON processing facility, specializing in
cannabis extraction. With the addition of Starseed Medicinal, a
medical-centric brand, Entourage has expanded its multi-channeled
distribution strategy. Starseed’s industry-first, exclusive
partnership with LiUNA, the largest construction union in Canada,
along with employers and union groups complements Entourage’s
direct sales to medical patients. In July 2021, Entourage signed a
definitive agreement to acquire craft cultivator CannTx Life
Sciences Inc. which operates out of its state-of-the-art
micropropagation and specialty extraction facility in Guelph,
Ontario. Upon the expected closing in late summer 2021, craft brand
Royal City Cannabis will be added to Entourage’s elite product
portfolio. The Company maintains strategic relationships in the
seniors’ market and supply agreements with Shoppers Drug Mart as
well as eight provincial distribution agencies where adult-use
brands Color Cannabis and Saturday Cannabis are sold. Entourage is
also the exclusive Canadian producer and distributor of
award-winning U.S.-based wellness brand Mary’s Medicinals sold in
both medical and adult-use channels and recently announced an
exclusive collaboration with The Boston Beer Company subsidiary to
launch cannabis-infused beverages in Canada with production
commencing in Q4, 2021 and product launch in 2022.
About Fire & Flower
Fire & Flower is a leading purpose-built,
independent adult-use cannabis retailer focused on the Canadian
market and international expansion opportunities. The Company
guides consumers through the complex world of cannabis through
education-focused, best-in-class retailing while the Hifyre™
digital platform connects cannabis consumers with cannabis
products. The Company’s leadership team combines extensive
experience in the cannabis industry with strong capabilities in
retail operations. Fire & Flower is a multi-banner cannabis
retail operator that owns and operates the Fire & Flower,
Friendly Stranger, Happy Dayz and Hotbox brands. Fire &
Flower Holdings Corp. owns all issued and outstanding shares in
Fire & Flower Inc. and Friendly Stranger Holdings Corp.,
licensed cannabis retailers that own and operate cannabis retail
stores in the provinces of British Columbia, Alberta, Saskatchewan,
Manitoba and Ontario and the Yukon territory. Through the
strategic investment of Alimentation Couche-Tard Inc., (owner of
Circle K convenience stores), the Company has set its sights on the
global expansion as new cannabis markets emerge. More
information on Fire & Flower can be found
at www.fireandflower.com.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on
LinkedIn
Twitter: Entourage,
Color Cannabis, Saturday
Cannabis &
Starseed
Instagram: Entourage, Color Cannabis, Saturday
Cannabis & Starseed
For further information, please
contact:
For Investor Enquiries:Valter
PintoManaging Director KCSA Strategic
Communications1-212-896-1254entourage@kcsa.com
For Media Enquiries:Marianella
delaBarreraSVP, Communications & Corporate
Affairs416-897-6644marianella@weedmd.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Jul 2023 to Jul 2024